Skip to main content

Dr Lee Price


Managerial responsibilities

Pathologist-in-Charge Department of Biochemistry. Member of SNP Executive Advisory Committee.




Clinical chemistry, Endocrinology, Toxicology


Bowen Hills QLD


Dr Lee Price is Pathologist-in-Charge of the Sullivan Nicolaides Pathology Department of Biochemistry. As well as overarching responsibility for the department, he reports across all aspects of clinical chemistry and endocrinology and works closely with clinicians.

A graduate of The University of Queensland, Dr Price trained in chemical pathology at Princess Alexandra Hospital and was awarded Fellowship of the Royal College of Pathologists of Australasia in 1994. As a Resident at Princess Alexandra Hospital, he became involved in endocrinology outpatient clinics and found he enjoyed the clinical camaraderie and contact with patients. He went on to advanced physician training in endocrinology at Princess Alexandra Hospital and later, at Concord Hospital. He was granted Fellowship of the Royal Australasian College of Physicians in 1999.  

On completion of his training, Dr Price took up a position with the Queensland Health Pathology Service at Royal Brisbane and Women'd Hospital where the Metabolic Studies screening unit under Dr Alan Clague had established a national reputation for its extensive work in inborn errors of metabolism. Performing a wide range of conventional and esoteric testing, it was one the first hospitals nationally to introduce mass spectrometry for neonatal screening.

In 2004, he joined SNP and later became Pathologist-in-Charge of Biochemistry. As the Sonic Healthcare referral centre for biochemistry and endocrinology, a key goal was to maintain the department's position at the forefront of scientific innovation. Under his leadership, the scope of testing has expanded into many new areas and biochemistry has become one of the largest departments of its kind in Australia, offering everything from routine tests on world-class automated analytical systems to esoteric tests performed manually. It has been responsible for many 'firsts' - the first pathology laboratory in Australia to offer anti-mullerian hormone (AMH); the first with the HE4 (ovarian and endometrial cancer marker); and the first, globally, to routinely offer the Enhanced Liver Fibrosis (ELF) test for liver fibrosis. It was also the first offering NATA-accredited testing for therapeutic drug monitoring and environmental testing (PFOS and PFOA).

Dr Price derives great professional satisfaction from working closely with clinicians and their patients. As both a chemical pathologist and endocrine physician, a key part of his job is advising clinicians on the interpretation of pathology results and their implications for patient management. When test results arrive after hours, he can find himself directly consulting with patients - especially in urgent situations.

As part of his responsibility for the day-to-day running of the Biochemistry Department, he serves on the SNP Executive Advisory Committee which sets the strategic direction of the practice. A Member (with commendation) of the Australasian Association of Biochemists, he publishes in his fields of interest and presents at AACB and RCPA annual meetings. He is also an examiner for the RCPA.